Handbook of Health Economics, Volume 2Mark V. Pauly, Thomas G. McGuire, Pedro Pita Barros What new theories, evidence, and policies have shaped health economics in the 21st century? Editors Mark Pauly, Thomas McGuire, and Pedro Pita Barros assemble the expertise of leading authorities in this survey of substantive issues. In 16 chapters they cover recent developments in health economics, from medical spending growth to the demand for health care, the markets for pharmaceutical products, the medical workforce, and equity in health and health care. Its global perspective, including an emphasis on low and middle-income countries, will result in the same high citations that made Volume 1 (2000) a foundational text.
|
Contents
| 45 | |
3 The Economics of Risky Health Behaviors | 95 |
Evidence from Randomized Evaluations | 201 |
5 Demand for Health Insurance | 317 |
6 Who Ordered That? The Economics of Treatment Choices in Medical Care | 397 |
7 Theoretical Issues Relevant to the Economic Evaluation of Health Technologies | 433 |
8 Cost Effectiveness and Payment Policy | 471 |
9 Competition in Health Care Markets | 499 |
11 Health Care Spending Risk Health Insurance and Payment to Health Plans | 691 |
12 Markets for Pharmaceutical Products | 763 |
13 Intellectual Property Information Technology Biomedical Research and Marketing of Patented Products | 825 |
14 Medical Workforce | 873 |
15 Public and Private Sector Interface | 927 |
16 Equity in Health and Health Care | 1003 |
| 1093 | |
10 Health Care Markets Regulators and Certifiers | 639 |
Other editions - View all
Common terms and phrases
addictive adverse selection alcohol approach areas average benefits choice clinical competition consumers consumption contract cost sharing cost-effectiveness analysis countries coverage Dafny decision discount disease Dranove drug effects efficiency empirical employer enrollees entry equilibrium estimate evidence example expenditures factors firms Health Affairs health behaviors health care Health Economics health insurance markets health plan higher hospital mergers hyperbolic discounting impact implies incentives income increase individual innovation instrumental variables intervention Journal of Economics Journal of Health Kenya literature lower managed managed care marginal market structure McGuire measures Medicare Medicare Part D Medicine monopsony moral hazard mortality Newhouse obesity optimal outcomes patients payment percent pharmaceutical physicians premium price elasticity providers QALY rates rational addiction reduce regulation report cards risk adjustment smoking social spending growth studies tion treatment utility variation welfare